LCM
MLAB icon

Lafitte Capital Management’s Mesa Laboratories MLAB Stock Holding History

Lafitte Capital Management’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-28,943
Closed -$1.95M – 26
2013
Q3 		$1.95M Sell
28,943
-11,057
-28% -$707K 1.46% 18
2013
Q2 		$2.17M Buy
+40,000
New +$2.08M 1.93% 16

Other funds holding MLAB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Mawer Investment Management
Mawer Investment Management Calgary, Alberta, Canada $15.4B AUM 10.9% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Lafitte Capital Management's MLAB Position: Q4 2013 in Review

Lafitte Capital Management sold out of Mesa Laboratories (MLAB) in Q4 2013, closing a stake of 28,943 shares — an estimated $1.95M sold.

Lafitte Capital Management first reported a position in MLAB in Q2 2013 and held it in 2 quarters. The position peaked at $2.17M in Q2 2013. 64 funds tracked by Wall St. Rank hold MLAB as of Q4 2013.

  • Lafitte Capital Management reported no remaining Mesa Laboratories position as of Q4 2013 after selling out during the quarter.
  • Lafitte Capital Management sold 28,943 Mesa Laboratories shares in Q4 2013, an estimated $1.95M.
  • Lafitte Capital Management first reported a position in Mesa Laboratories in Q2 2013 and held it in 2 quarters.
  • Lafitte Capital Management's Mesa Laboratories position peaked at $2.17M in Q2 2013.
  • 64 funds tracked by Wall St. Rank held Mesa Laboratories as of Q4 2013.

Based on Lafitte Capital Management's 13F filing for Q4 2013, filed 14 Feb 2014.